Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,527 | 180 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $584.77 | 36 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $487.74 | 17 | $0 (2024) |
| Amgen Inc. | $414.45 | 20 | $0 (2024) |
| Merck Sharp & Dohme LLC | $298.16 | 12 | $0 (2024) |
| Novo Nordisk Inc | $285.31 | 14 | $0 (2024) |
| ABBVIE INC. | $259.03 | 15 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $247.98 | 12 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $187.66 | 7 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $143.83 | 9 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $88.17 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,286 | 67 | Lilly USA, LLC ($295.53) |
| 2023 | $1,326 | 63 | Lilly USA, LLC ($224.76) |
| 2022 | $386.05 | 25 | Amgen Inc. ($60.88) |
| 2021 | $529.76 | 25 | AstraZeneca Pharmaceuticals LP ($271.15) |
All Payment Transactions
180 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Respiratory | ||||||
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.85 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Bone Health | ||||||
| 11/25/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: RESPIRATORY | ||||||
| 11/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Cardio-renal | ||||||
| 11/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Oncology | ||||||
| 11/08/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $26.53 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $94.50 | General |
| Category: Obesity | ||||||
| 10/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Hepatitis B Vaccine | ||||||
| 10/14/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.17 | General |
| 09/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Bone Health | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.41 | General |
| 09/09/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Diabetes | ||||||
| 09/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 676 | 1,008 | $115,014 | $39,017 |
| 2022 | 12 | 618 | 808 | $105,720 | $39,412 |
| 2021 | 9 | 685 | 947 | $90,350 | $35,178 |
| 2020 | 13 | 720 | 1,048 | $92,080 | $32,544 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 124 | 229 | $55,647 | $15,402 | 27.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 86 | 86 | $21,328 | $8,933 | 41.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 97 | $16,684 | $4,459 | 26.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $6,890 | $3,668 | 53.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 26 | 28 | $4,081 | $1,997 | 48.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 97 | 157 | $1,570 | $1,311 | 83.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 26 | 28 | $1,614 | $800.80 | 49.6% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 15 | 17 | $1,054 | $532.00 | 50.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 34 | 51 | $1,581 | $477.09 | 30.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 110 | 194 | $1,552 | $424.85 | 27.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $728.00 | $371.80 | 51.1% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 33 | 54 | $702.00 | $324.34 | 46.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 22 | $880.00 | $197.55 | 22.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 16 | 19 | $703.00 | $119.08 | 16.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 145 | 221 | $47,225 | $15,054 | 31.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 86 | 86 | $20,342 | $8,959 | 44.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 94 | 133 | $19,936 | $6,500 | 32.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 17 | 17 | $8,498 | $4,738 | 55.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 24 | 24 | $3,332 | $1,642 | 49.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 26 | 27 | $1,476 | $700.99 | 47.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 22 | 22 | $1,034 | $595.19 | 57.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 33 | 44 | $1,364 | $422.32 | 31.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 103 | 154 | $1,115 | $346.42 | 31.1% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 30 | 42 | $580.00 | $259.20 | 44.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 15 | 15 | $555.00 | $120.32 | 21.7% |
About Ruby Leach, APRN
Ruby Leach, APRN is a Nurse Practitioner healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376637942.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ruby Leach, APRN has received a total of $3,527 in payments from pharmaceutical and medical device companies, with $1,286 received in 2024. These payments were reported across 180 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($3,527).
As a Medicare-enrolled provider, Leach has provided services to 2,699 Medicare beneficiaries, totaling 3,811 services with total Medicare billing of $146,151. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Lexington, KY
- Active Since 10/03/2006
- Last Updated 12/08/2020
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1376637942
Products in Payments
- MOUNJARO (Drug) $347.42
- BREZTRI (Drug) $326.60
- GVOKE HYPOPEN (Drug) $201.56
- QUVIVIQ (Drug) $187.66
- Repatha (Biological) $165.81
- JARDIANCE (Drug) $148.19
- VRAYLAR (Drug) $137.72
- Wegovy (Drug) $119.01
- FARXIGA (Drug) $118.18
- EVENITY (Biological) $112.51
- QULIPTA (Drug) $105.92
- VAXNEUVANCE (Biological) $103.50
- LEQVIO (Drug) $101.45
- Kerendia (Drug) $88.17
- Otezla (Drug) $82.17
- EMGALITY (Drug) $69.74
- GARDASIL 9 (Biological) $66.32
- Cologuard Collection Kit (Device) $63.06
- Aimovig (Biological) $53.96
- ROTATEQ (Biological) $52.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Lexington
Rachael Bradford, Aprn, APRN
Nurse Practitioner — Payments: $369,931
Jessica Schorck, Aprn, APRN
Nurse Practitioner — Payments: $19,669
Juawanna Schuller, Arnp, ARNP
Nurse Practitioner — Payments: $19,426
Mrs. Megan Collett, Aprn, APRN
Nurse Practitioner — Payments: $10,839
Holly Chitwood, Aprn, APRN
Nurse Practitioner — Payments: $8,212
Robin Sutcliffe, Aprn, APRN
Nurse Practitioner — Payments: $8,003